Price (delayed)
$149.2
Market cap
$8.36B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.14
Enterprise value
$8.25B
Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is based in Waltham, Massachusetts, and incorporated in
There are no recent dividends present for RGEN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.